TCR Medical Corporation   Report issue

Academic/Hospital Phase 1
Founded: San Diego CA United States (2003)

Organization Overview

First Clinical Trial
2016
NCT02748902
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Neal D. Bhatia, MD

Active Ingredients

Drugs in Phase 1 Trials (1)

ingenol mebutate (picato) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Warts (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1